These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1114 related articles for article (PubMed ID: 11841535)

  • 1. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.
    Verrecchia F; Mauviel A
    J Invest Dermatol; 2002 Feb; 118(2):211-5. PubMed ID: 11841535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing.
    Schiller M; Javelaud D; Mauviel A
    J Dermatol Sci; 2004 Aug; 35(2):83-92. PubMed ID: 15265520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis.
    Verrecchia F; Mauviel A; Farge D
    Autoimmun Rev; 2006 Oct; 5(8):563-9. PubMed ID: 17027893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta and fibrosis.
    Verrecchia F; Mauviel A
    World J Gastroenterol; 2007 Jun; 13(22):3056-62. PubMed ID: 17589920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta: a key mediator of fibrosis.
    Mauviel A
    Methods Mol Med; 2005; 117():69-80. PubMed ID: 16118446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis.
    Verrecchia F; Mauviel A
    Curr Rheumatol Rep; 2002 Apr; 4(2):143-9. PubMed ID: 11890880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
    Javelaud D; Mauviel A
    Oncogene; 2005 Aug; 24(37):5742-50. PubMed ID: 16123807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma.
    Ihn H
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):325-31. PubMed ID: 12455866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
    Baldwin RL; Tran H; Karlan BY
    Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transforming growth factor-betas: smad signaling and roles in physiopathology].
    Javelaud D; Mauviel A
    Pathol Biol (Paris); 2004 Feb; 52(1):50-4. PubMed ID: 14761714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of transforming growth factor-beta signaling.
    Zhu HJ; Burgess AW
    Mol Cell Biol Res Commun; 2001 Nov; 4(6):321-30. PubMed ID: 11703090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability.
    Zhu S; Goldschmidt-Clermont PJ; Dong C
    Circ Res; 2004 Mar; 94(5):617-25. PubMed ID: 14739161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIP1 (Smad interacting protein 1) and deltaEF1 (delta-crystallin enhancer binding factor) are structurally similar transcriptional repressors.
    van Grunsven LA; Schellens A; Huylebroeck D; Verschueren K
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S40-7. PubMed ID: 11263664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid remodels extracellular matrix (ECM) of cultured human fetal palate mesenchymal cells (hFPMCs) through down-regulation of TGF-β/Smad signaling.
    Li X; Zhang L; Yin X; Gao Z; Zhang H; Liu X; Pan X; Li N; Yu Z
    Toxicol Lett; 2014 Mar; 225(2):208-15. PubMed ID: 24374174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling.
    Ding ZY; Jin GN; Liang HF; Wang W; Chen WX; Datta PK; Zhang MZ; Zhang B; Chen XP
    Cell Signal; 2013 Oct; 25(10):1981-92. PubMed ID: 23727026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
    He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
    Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells.
    Rodeck U; Nishiyama T; Mauviel A
    Cancer Res; 1999 Feb; 59(3):547-50. PubMed ID: 9973198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W; Koka V; Lan HY
    Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.